Product Program year 2025 Source: CMS Open Payments

OsteoStrand Plus

Device Bone matrix implant, composite

Open in the dashboard

General payments

$403,273

126 payments

Research payments

$4,096

2 payments

Through program year 2025, $403,273 in general payments and $4,096 in research payments were reported against OsteoStrand Plus (Bone matrix implant, composite).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $11,164 36
2024 General $194,621 56
2024 Research $3,565 1
2023 General $197,488 34
2023 Research $531 1

Breakdown

Who paid General payments · program years 2023–2025
  1. Orthofix Medical, Inc. $403,273 126 payments
Top recipients General payments · program year 2025
  1. Scott McGovern Orthopaedic Surgery of the Spine · Salisbury, MD $7,125 64% · 1 payment
  2. Harvinder Sandhu Orthopaedic Surgery of the Spine · New York, NY $1,913 17% · 2 payments
  3. Nolan Wessell Orthopaedic Surgery of the Spine · Aurora, CO $416 4% · 1 payment
  4. Erich Anderer Neurological Surgery · Brooklyn, NY $230 2% · 2 payments
  5. Jayant Jagannathan Neurological Surgery · Troy, MI $164 1% · 1 payment

The top 5 of 32 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Orthopaedic Surgery of the Spine Orthopaedic Surgery $9,790 88% · 8 practitioners
  2. Neurological Surgery $686 6% · 8 practitioners
  3. Orthopaedic Surgery $207 2% · 7 practitioners
  4. Physician Assistant, Surgical Physician Assistant $200 2% · 4 practitioners
  5. Pulmonary Disease Internal Medicine $102 <1% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $7,125 64% · 1 recipient
  2. New York $2,626 24% · 13 recipients
  3. Colorado $416 4% · 1 recipient
  4. Pennsylvania $401 4% · 8 recipients
  5. Michigan $164 1% · 1 recipient

The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

126 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record